Evidence map›Paper›PMID 26625893›Full record

ArticleThe international journal of neuropsychopharmacology2016

Supersensitive Kappa Opioid Receptors Promotes Ethanol Withdrawal-Related Behaviors and Reduce Dopamine Signaling in the Nucleus Accumbens.

Jamie H Rose, Anushree N Karkhanis, Rong Chen, Dominic Gioia, Marcelo F Lopez, Howard C Becker, Brian A McCool, Sara R Jones

Open access · goldAbstract read
In one paragraph

Article in The international journal of neuropsychopharmacology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 101 papers.

0numbers the graph read from it
0cells of the map it votes in
101citing papers in PubMed
5.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

101 citing papers in PubMed, 143 citations in OpenAlex.

  1. Review
  2. Article
  3. Kappa opioid receptor control of motivated behavior revisited.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Synaptic Effects Induced by Alcohol.Current topics in behavioral neurosciences · 2025
    Review
  16. Chronic alcohol withdrawal-associated increases in VTAAdvances in drug and alcohol research · 2025
    Article
  17. Review
  18. Article
  19. Article
  20. Article

41 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jamie H RoseDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Anushree N KarkhanisDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Rong ChenDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Dominic GioiaDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Marcelo F LopezDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Howard C BeckerDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Brian A McCoolDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker).
Sara R JonesDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, North Carolina (Dr Rose, Dr Karkhanis, Dr Chen, Mr Gioia, Dr McCool, and Dr Jones); Charleston Alcohol Research Center (Drs Lopez and Becker), Department of Psychiatry (Drs Lopez and Becker), and Department of Neurosciences (Dr Becker), Medical University of South Carolina, Charleston, South Carolina; RHJ Department of Veterans Affairs Medical Center, Charleston, South Carolina (Dr Becker). srjones@wakehealth.edu.
Wake Forest University · USMedical University of South Carolina · US

Funding

TREATING ETHANOL WITHDRAWAL WITH LORAZEPAM/NALTREXONEP50AA010761 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Lisa M McTeague · 1996 to 2026
$46.8M
TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI PORRINO, LINDA J. · 1991 to 2019
$30.8M
MULTI-DISCIPLINARY TRAINING IN THE BIOLOGY OF ALCOHOLISMT32AA007565 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI BRIAN A MCCOOL · 1994 to 2026
$10.1M
Ethanol Dependence &Stress Effects on Ethanol DrinkingU01AA014095 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI HOWARD C. BECKER · 2003 to 2026
$9.0M
Role of Kappa Opioid Receptors in Maladaptive Catecholamine Responses to Stress and Alcohol ExposureU01AA014091 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Katherine Mercedes Holleran, SARA RAULERSON JONES · 2003 to 2026
$7.7M
The Ethanol - Anxiety Interaction: Cellular MechanismsR01AA014445 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCOOL, BRIAN A · 2004 to 2023
$5.2M
Translational Studies on Early-life Stress and Vulnerability to Alcohol AddictionP01AA021099 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI WEINER, JEFFREY L. · 2012 to 2016
$2.8M
Mouse Chronic Intermittent Ethanol (CIE) CoreU01AA020929 · NIAAA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI LOPEZ, MARCELO F. · 2012 to 2015
$1.5M
Withdrawal-Stress, Anxiety, and Amygdala NeurophysiologyU01AA020942 · NIAAA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI MCCOOL, BRIAN A · 2012 to 2016
$911k
Role of BDNF in Stress Effects on Ethanol Dependence-Induced Escalated DrinkingI01BX000813 · VA · RALPH H JOHNSON VA MEDICAL CENTER · PI BECKER, HOWARD C. · 2011 to 2024
–
NIAAA NIH HHS P01 AA021099NIAAA NIH HHS P50 AA010761NIAAA NIH HHS R01 AA014445NIAAA NIH HHS T32 AA007565NIAAA NIH HHS U01 AA014091NIAAA NIH HHS U01 AA014095NIAAA NIH HHS U01 AA020929NIAAA NIH HHS U01 AA020942NIDA NIH HHS P50 DA006634
6 · The paper itself

Abstract

backgroundChronic ethanol exposure reduces dopamine transmission in the nucleus accumbens, which may contribute to the negative affective symptoms associated with ethanol withdrawal. Kappa opioid receptors have been implicated in withdrawal-induced excessive drinking and anxiety-like behaviors and are known to inhibit dopamine release in the nucleus accumbens. The effects of chronic ethanol exposure on kappa opioid receptor-mediated changes in dopamine transmission at the level of the dopamine terminal and withdrawal-related behaviors were examined.

methodsFive weeks of chronic intermittent ethanol exposure in male C57BL/6 mice were used to examine the role of kappa opioid receptors in chronic ethanol-induced increases in ethanol intake and marble burying, a measure of anxiety/compulsive-like behavior. Drinking and marble burying were evaluated before and after chronic intermittent ethanol exposure, with and without kappa opioid receptor blockade by nor-binaltorphimine (10mg/kg i.p.). Functional alterations in kappa opioid receptors were assessed using fast scan cyclic voltammetry in brain slices containing the nucleus accumbens.

resultsChronic intermittent ethanol-exposed mice showed increased ethanol drinking and marble burying compared with controls, which was attenuated with kappa opioid receptor blockade. Chronic intermittent ethanol-induced increases in behavior were replicated with kappa opioid receptor activation in naïve mice. Fast scan cyclic voltammetry revealed that chronic intermittent ethanol reduced accumbal dopamine release and increased uptake rates, promoting a hypodopaminergic state of this region. Kappa opioid receptor activation with U50,488H concentration-dependently decreased dopamine release in both groups; however, this effect was greater in chronic intermittent ethanol-treated mice, indicating kappa opioid receptor supersensitivity in this group.

conclusionsThese data suggest that the chronic intermittent ethanol-induced increase in ethanol intake and anxiety/compulsive-like behaviors may be driven by greater kappa opioid receptor sensitivity and a hypodopaminergic state of the nucleus accumbens.

Indexed as

Behavior, AnimalEthanolSynaptic TransmissionAlcohol DrinkingAlcohol-Induced Disorders, Nervous SystemAnalgesics, OpioidAnimalsAnxietyCompulsive BehaviorDisease Models, AnimalDopamineDopaminergic NeuronsDose-Response Relationship, DrugIn Vitro TechniquesMaleMice, Inbred C57BLAnalgesics, OpioidDopamineEthanolNarcotic AntagonistsReceptors, Opioid, kappaanxietycompulsionreleaseuptakevoltammetry

Identifiers

PMID26625893
PMCPMC4886667
OpenAlexW2258001964

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.